Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall be performed in a manner consistent with BMS’ normal practices used to prepare its audited financial statements for internal and external reporting purposes.
Appears in 13 contracts
Sources: Collaboration and License Agreement (Exscientia LTD), Collaboration and License Agreement (Ambrx Biopharma Inc.), Collaboration and License Agreement (Ambrx Biopharma Inc.)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall be performed in a manner consistent with BMS’ normal practices used to prepare its audited financial statements for internal and external reporting purposes, which uses a widely accepted source of published exchange rates.
Appears in 12 contracts
Sources: Collaboration Agreement (Exelixis, Inc.), Collaboration Agreement (Exelixis Inc), Collaboration Agreement (Exelixis Inc)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall be performed in a manner consistent with BMS’ normal practices used to prepare its audited financial statements for internal and external reporting purposes.
Appears in 5 contracts
Sources: Collaboration and License Agreement (CytomX Therapeutics, Inc.), Collaboration and License Agreement (CytomX Therapeutics, Inc.), Collaboration and License Agreement (CytomX Therapeutics, Inc.)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars U.S. dollars shall be performed in a manner consistent with BMS’ Ambrx’s normal practices used to prepare its audited financial statements for internal and external reporting purposes.
Appears in 3 contracts
Sources: Collaborative License Agreement (Ambrx Biopharma Inc.), Collaborative License Agreement (Ambrx Biopharma Inc.), Collaborative License Agreement (Ambrx Inc)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall be performed in a manner consistent with BMS’ ’s normal practices used to prepare its audited financial statements for internal and external reporting purposes.
Appears in 3 contracts
Sources: Option and License Agreement (Bavarian Nordic a/S / ADR), Option and License Agreement (Bavarian Nordic a/S / ADR), Option and License Agreement (Bavarian Nordic a/S / ADR)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars Euros shall be performed in a manner consistent with BMS’ Servier’s normal practices used to prepare its audited financial statements for internal and external reporting purposes, which uses a widely accepted source of published exchange rates.
Appears in 3 contracts
Sources: Collaboration and License Agreement (Clovis Oncology, Inc.), Collaboration and License Agreement (XOMA Corp), Collaboration and License Agreement (Xoma LTD /De/)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall will be performed in a manner consistent with BMS’ Kite’s normal practices used to prepare its audited financial statements for internal and external reporting purposes.
Appears in 2 contracts
Sources: License and Research Agreement (Alpine Immune Sciences, Inc.), License and Research Agreement (Kite Pharma, Inc.)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall be performed in a manner consistent with BMSExactus BioSolutions’ normal practices used to prepare its audited financial statements for internal and external reporting purposes.
Appears in 1 contract
Sources: Collaboration and License Agreement (Exactus, Inc.)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall be performed in a manner consistent with BMS’ GAAP and Hanmi’s normal practices used to prepare its audited financial statements for internal and external reporting purposes.
Appears in 1 contract
Sources: Collaboration and License Agreement (RAPT Therapeutics, Inc.)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall be performed in a manner consistent with BMS’ ContraFect’s normal practices used to prepare its audited financial statements for internal and external reporting purposes.
Appears in 1 contract
Sources: License Agreement (CONTRAFECT Corp)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall be performed in a manner consistent with BMS’ BeiGene’s normal practices used to prepare its audited financial statements for internal and external reporting purposes.
Appears in 1 contract
Sources: Collaboration and Exclusive License Agreement (Ambrx Biopharma Inc.)
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall U.S. dollars will be performed in a manner consistent with BMS’ normal practices used to prepare its audited financial statements for internal and external reporting purposes, which uses a widely accepted source of published exchange rates.
Appears in 1 contract
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars U.S. dollars shall be performed in a manner consistent with BMS’ normal practices used to prepare its audited financial statements for internal and external reporting purposes, which uses a widely accepted source of published exchange rates.
Appears in 1 contract
Foreign Exchange. Conversion of sales recorded in local currencies to Dollars shall will be performed in a manner consistent with BMSClovis’ normal practices used to prepare its audited financial statements for internal and external reporting purposes, which uses a widely accepted source of published exchange rates.
Appears in 1 contract
Sources: License and Collaboration Agreement (Clovis Oncology, Inc.)